Astellas Pharma: total assets 2021

In the fiscal year 2021, Astellas Pharma held assets worth approximately 2.33 trillion Japanese yen, indicating that the previous fiscal year with its total assets of 2.27 trillion yen was only a momentary setback on a general upward trend. The main areas of the Japanese pharmaceutical company include urology, immunology, cardiology, and infectious diseases.

Total assets of Astellas Pharma Inc. from fiscal year 2012 to 2021 (in trillion Japanese yen)

Characteristic	Total assets in trillion Japanese yen
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

April 2022

More information

Region

Japan

Survey time period

fiscal year 2012 to 2021; the company's fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Special properties

consolidated data

Supplementary notes

Astellas Pharma Inc. has adopted International Financial Reporting Standards (IFRS) since the fiscal year ended March 31, 2014. Figures up to fiscal year ended March 31, 2014, are based on Japanese generally accepted accounting principles (J-GAAP).

100 Japanese yen equal 0.74 U.S. dollars or 0.70 euros as of December 2022.
Data prior to 2020 comes from previous reporting.

Citation formats